Related Experiment Video
Updated: Jun 22, 2026

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE
Ajay J Kirtane1, Eugene R Heyman, Christopher Metzger
1Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York, USA.
Insights
Longer lesion length in saphenous vein grafts (SVGs) is the primary predictor of adverse events after percutaneous coronary intervention (PCI). This finding holds true even for relatively short lesions, highlighting the importance of lesion length in PCI outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Major adverse cardiac events (MACE) remain a concern for patients undergoing saphenous vein graft (SVG) intervention, despite the use of distal embolic protection devices.
- Predictors of MACE in this patient group are not well-defined, necessitating further investigation.
Purpose of the Study:
- To identify correlates of 30-day adverse events in patients undergoing percutaneous coronary intervention (PCI) of SVGs.
- To characterize major predictors of MACE among patients undergoing SVG intervention with distal embolic protection.
Main Methods:
- Analysis of 631 patients from the PRIDE study undergoing SVG intervention with distal embolic protection.
- Assessment of correlates for 30-day MACE and peri-procedural creatine kinase-myocardial band (CK-MB) elevation.
- Comparison of TriActiv System against active control devices (Guardwire or Filterwire).
Main Results:
- Longer lesion length, greater plaque volume, and higher SVG degeneration score were associated with MACE.
- Angiographic lesion length was the strongest independent correlate of MACE (OR 2.81) and CK-MB elevation (OR 2.54).
- A graded increase in MACE was observed with increasing lesion lengths, consistent across different embolic protection devices.
Conclusions:
- Angiographic lesion length is the most significant correlate of short-term adverse events in SVG intervention with distal embolic protection.
- Adverse event risk increases incrementally with lesion length, even at shorter lengths.
- These findings emphasize the critical role of lesion length in predicting outcomes during SVG PCI.
Objectives:
We sought to identify correlates of 30-day adverse events among patients undergoing percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG).
Background:
Although the use of distal embolic protection devices during SVG intervention reduces major adverse cardiac events (MACE), many patients still experience MACE despite distal embolic protection, and the major predictors of MACE among these patients are not well-characterized.
Methods:
Correlates of 30-day MACE and peri-procedural creatine kinase-myocardial band (CK-MB) elevation were assessed among 631 patients undergoing SVG intervention with distal embolic protection enrolled in the PRIDE (PRotection during saphenous vein graft Intervention to prevent Distal Embolization) study, a randomized comparison of the TriActiv System (Kensey-Nash Corp., Exton, Pennsylvania) with an active control group (Guardwire [Medtronic, Santa Clara, California] or Filterwire [Boston Scientific, Minneapolis, Minnesota]).
Results:
Baseline covariates associated with MACE were longer lesion length, greater angiographically assessed estimated plaque volume, and higher SVG degeneration score. Graft age and angina class were not associated with adverse events. Angiographic lesion length was significantly correlated with more complex angiographic metrics such as estimated plaque volume and the SVG degeneration score. In multivariable analyses, angiographic lesion length was the strongest independent correlate of MACE (odds ratio [OR] 2.81 [95% confidence interval (CI) 1.82 to 4.34]/log-increase in lesion length, p < 0.001) with a graded increase in MACE observed with increasing lesion lengths. Similarly, the strongest independent correlate of CK-MB elevation was lesion length (OR 2.54 [95% CI 1.59 to 4.04]/log-increase in lesion length, p < 0.001). The associations between lesion length and both MACE and CK-MB elevation were consistent among the studied embolic protection devices (TriActiv, Guardwire, or Filterwire).
Conclusions:
Angiographic lesion length was the strongest correlate of short-term adverse events among patients undergoing SVG intervention with distal embolic protection, with incremental effects noted at even relatively short lesion lengths.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
